Misinformation fuels distrust as Ebola outbreak worsens in Democratic Republic of Congo
By
Rael Ombuor, Rachel Chason, Lauren Weber
Summary
A deadly Ebola outbreak in the eastern Democratic Republic of Congo is being worsened by the spread of conspiracy theories, including false claims that nonprofit workers brought the disease to secure funding, and that the outbreak is fabricated to frighten the population and gain access to mineral resources like gold. Distrust and violence are flaring as misinformation undermines public health efforts.
Source

Key quotes
· 3 pulledOne conspiracy theory is that nonprofit workers brought the disease to get more money.
Another is that the outbreak has been fabricated to frighten the population and gain access to minerals, including gold.
Distrust and violence flare in the Democratic Republic of Congo as false claims spread that the outbreak — and the disease itself — is a hoax.
You might also wanna read
Ebola Outbreak Worsens in Congo Amid Questions Over US Foreign Aid Cuts
The article examines the escalating Ebola outbreak in the Democratic Republic of Congo, which began in a mining village near the South Sudan
At least 100 dead in DR Congo Ebola outbreak, Africa CDC confirms
At least 100 deaths have been reported in an Ebola outbreak in the Democratic Republic of Congo, with more than 390 suspected cases. The hea
Ebola outbreak in DRC becomes third largest recorded with nearly 750 cases and 177 deaths
The Ebola outbreak in the Democratic Republic of the Congo's Ituri province has become the third largest on record, with nearly 750 cases, 1
arstechnica.com·1mo agoWHO Declares Ebola Outbreak in DRC and Uganda a Global Health Emergency
The World Health Organization declared the Ebola outbreak in the Democratic Republic of Congo and Uganda a global health emergency. The anno

Understanding Ebola’s wildlife origins is crucial to preventing next big outbreak
U.S. Provides Experimental Ebola Drug for Clinical Trials in Congo Amid Worsening Outbreak
The U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for clinical trials to combat the worsening Ebola o

Comments
Sign in to join the conversation.
No comments yet. Be the first.